ABBOTT LABORATORIES — Director's Dealing 2017

Jun 3, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2017-06-01

Reporting Person: LANE ANDREW H (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-06-01	Common shares without par value	A	3007	—	Acquired	23495	Direct
2017-06-01	Common shares without par value	F	602	$45.66	Disposed	22893	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	841	Indirect

Footnotes

F1: Settlement of a performance-based restricted stock unit in shares in a transaction exempt from Section 16(b) under Rule 16b-3.

F2: Balance in the Abbott Laboratories Stock Retirement Trust as of June 1, 2017.